Strides Pharma receives FDA Form 483 citing 5 observations
NewsBytes | May 21, 2026 3:39 AM CST
Strides Pharma Form 483 15-day response
A Form 483 is like an official heads-up from the FDA about possible rule violations, but it doesn't mean final judgment yet.
Strides has 15 days to explain how it will fix things.
After this news, its stock dipped slightly, closing at ₹1,145.
READ NEXT
-
Mohamed Salah, Vinicius Jr and 20 Footballers Set to Shape the 2026 Summer Transfer Market

-
Eight Defining Matches That Sealed Arsenal’s 2025-26 Premier League Triumph

-
WSL Player of the Year 2025-26: Lauren James, Khadija Shaw, Alessia Russo and GOAL’s Top 20 Rankings Revealed

-
5 Bhagavad Gita Shlokas on How to Overcome the Fear of Failure

-
Celebrities Share Their Ideal Tea Moments on International Tea Day
